1-18 of 18
Elizabeth Raetz, MD
Close
Sort by
Articles

Simplifying 6-MP Delivery

Luke Maese, DO, Elizabeth Raetz, MD
Journal: The Hematologist
The Hematologist (2017) 15 (1)
https://doi.org/10.1182/hem.V15.1.8118
Published: 2017
Articles

Predicting Responses to Gemtuzumab Ozogamicin

Elizabeth Raetz, MD
Journal: The Hematologist
The Hematologist (2017) 14 (6)
https://doi.org/10.1182/hem.V14.6.7883
Published: 2017
Articles

Abrogating Early Treatment Resistance in Early T-cell Precursor Acute Lymphoblastic Leukemia

Elizabeth Raetz, MD
Journal: The Hematologist
The Hematologist (2017) 14 (5)
https://doi.org/10.1182/hem.V14.5.7616
Published: 2017
Articles

Redefining Induction Failure

Elizabeth Raetz, MD
Journal: The Hematologist
The Hematologist (2017) 14 (4)
https://doi.org/10.1182/hem.V14.4.7471
Published: 2017
Articles

High Prevalence of Ph-Like ALL Across the Age Spectrum

Elizabeth Raetz, MD
Journal: The Hematologist
The Hematologist (2017) 14 (3)
https://doi.org/10.1182/hem.V14.3.7295
Published: 2017
Articles

Personalizing Therapy: The Beat AML Trial

Tibor Kovacsovics, MD, Elizabeth Raetz, MD
Journal: The Hematologist
The Hematologist (2017) 14 (2)
https://doi.org/10.1182/hem.V14.2.7134
Published: 2017
Articles

Tectonic Shifts in the 2016 Treatment Landscapes for Acute Lymphocytic Leukemia

Elizabeth Raetz, MD
Journal: The Hematologist
The Hematologist (2017) 14 (1)
https://doi.org/10.1182/hem.V14.1.7005
Published: 2017
Articles

Targeting CD22 in Adult Acute Lymphocytic Leukemia

Elizabeth Raetz, MD
Journal: The Hematologist
The Hematologist (2016) 13 (6)
https://doi.org/10.1182/hem.V13.6.6791
Published: 2016
Articles

Successful Treatment Reduction in Childhood ALL

Elizabeth Raetz, MD
Journal: The Hematologist
The Hematologist (2016) 13 (5)
https://doi.org/10.1182/hem.V13.5.6537
Published: 2016
Articles

Weighing the Pros and Cons of Dexamethasone Versus Prednisone in Childhood ALL Induction

Elizabeth Raetz, MD
Journal: The Hematologist
The Hematologist (2016) 13 (4)
https://doi.org/10.1182/hem.V13.4.5632
Published: 2016
Articles

Targeting JAK Pathway-Mutant Acute Lymphoblastic Leukemia

Mignon Loh, MD, Elizabeth Raetz, MD
Journal: The Hematologist
The Hematologist (2016) 13 (3)
https://doi.org/10.1182/hem.V13.3.5484
Published: 2016
Articles

Expanding the Mutational Spectrum in Juvenile Myelomonocytic Leukemia

Elizabeth Raetz, MD
Journal: The Hematologist
The Hematologist (2016) 13 (2)
https://doi.org/10.1182/hem.V13.2.5115
Published: 2016
Articles

A New Roadmap for Optimizing Thiopurine Therapy in Acute Lymphocytic Leukemia

Julia Meyer, PhD, Elizabeth Raetz, MD
Journal: The Hematologist
The Hematologist (2016) 13 (1)
https://doi.org/10.1182/hem.V13.1.4829
Published: 2016
Articles

Targeting the Purine Biosynthesis Pathway in Relapsed ALL

Elizabeth Raetz, MD
Journal: The Hematologist
The Hematologist (2015) 12 (6)
https://doi.org/10.1182/hem.V12.6.4492
Published: 2015
Articles

The Evolutionary Trajectory from Diagnosis to Relapse in Pediatric ALL

Elizabeth Raetz, MD
Journal: The Hematologist
The Hematologist (2015) 12 (5)
https://doi.org/10.1182/hem.V12.5.4312
Published: 2015
Articles

New Light on an Old Drug

Elizabeth Raetz, MD
Journal: The Hematologist
The Hematologist (2015) 12 (4)
https://doi.org/10.1182/hem.V12.4.4141
Published: 2015
Articles

Antibody Therapy for the Treatment of Relapsed ALL

Elizabeth Raetz, MD
Journal: The Hematologist
The Hematologist (2015) 12 (3)
https://doi.org/10.1182/hem.V12.3.3947
Published: 2015
Articles

H3K27 Demethylases: A New Therapeutic Target in T-ALL?

Elizabeth Raetz, MD
Journal: The Hematologist
The Hematologist (2015) 12 (2)
https://doi.org/10.1182/hem.V12.2.3700
Published: 2015